HYBRID PEPTIDE A NOVEL CLINICAL FRONTIER

Chimera molecules represent a significantly evolving domain in drug discovery, offering a unique approach to address previously intractable illnesses. These kind of designed assemblies combine several peptide motifs, permitting for optimized selectivity to diverse sites and maybe avoiding medicin